At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
BSC Deep Brain Stimulation System with Directional Leaddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Directional Lead: Investigation of Rotational Current Steering, Ease of Use of Clinical Effects Map, and Therapeutic Outcomes of Deep Brain Stimulation
In Brief
A clinical study evaluating BSC Deep Brain Stimulation System with Directional Lead for Parkinson Disease. Completed, enrolled 12 participants across 3 sites in 3 countries.
Detailed Summary
The primary objective is to characterize the programming effects of Boston Scientific Vercise™ PC System using the DBS Directional Lead for bilateral STN DBS for the treatment of Parkinson's disease in acute and chronic settings.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesFrance, Germany, Netherlands
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 2016
Enrollment StartJul 2016
Primary CompletionDec 2018
TodayJul 2026
First PostedJul 18, 2016
Enrollment StartJul 19, 2016
Primary CompletionDec 19, 2018
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 10.0 years ago
Interventions
BSC Deep Brain Stimulation System with Directional Leaddevice